Pulmonary embolism
534 results
101 - 200
Concurrent COVID-19 infection does not affect the sensitivity of D-dimer for pulmonary embolism diagnosis- Risk of recurrent venous thromboembolism is 3% in patients with subsegmental pulmonary embolism who are not anticoagulated
Vena caval filters for the prevention of pulmonary embolism- Extended anticoagulation for patients with low-risk pulmonary embolism and cancer has marginal benefit (ON COPE)
- Pulmonary Embolism (PE) Severity Index predicts low risk PE patients.
- Pulmonary embolism rule-out criteria reduces the need for CT pulmonary angiography in low-risk patients (PERC)
- Heparin, low molecular weight heparin and physical methods for preventing deep vein thrombosis and pulmonary embolism following surgery for hip fractures
- Oral direct thrombin inhibitors or oral factor Xa inhibitors versus conventional anticoagulants for the treatment of pulmonary embolism
- Catheter‐directed therapies for the treatment of high risk (massive) and intermediate risk (submassive) acute pulmonary embolism
- Prevalence of pulmonary embolism is 5.9% in patients with COPD who are hospitalized with acute respiratory symptoms
- Imaging for the exclusion of pulmonary embolism in pregnancy
- Sex as a prognostic factor for mortality in adults with acute symptomatic pulmonary embolism
Hyperventilation - YEARS clinical decision tool decreases CT angiography in patients with suspected PE
- Asthma: symptoms and diagnosis
- Haemoptysis
- Echocardiography as an outpatient procedure
- Guideline for Dx of PE in pregnant women
- Normal hs troponin and PESI score of 0 means great prognosis for PE
- Very few patients with syncope have pulmonary emboli
- Assessment of ventricular hypertrophies from an ECG
- Increased pulmonary blood pressure: pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension
- Dyspnoea
- Pleural effusions and thoracentesis
- Acute heart failure and pulmonary oedema
- Exercise stress test
- Oral direct thrombin inhibitors or oral factor Xa inhibitors for the treatment of deep vein thrombosis
- Deep vein thrombosis
- Guidelines for managing VTE (AAFP, ACP)
- Multidetector CT accurate for PE, but requires clinical context
- Pulmonary function tests
- LMWH better than UFH for acute DVT
- Low molecular weight heparin for prevention of venous thromboembolism in patients with lower‐limb immobilization
- Respiratory failure
- Thrombophilia testing for prevention of recurrent venous thromboembolism
- Interventions for preventing venous thromboembolism in adults undergoing knee arthroscopy
- Are inferior vena cava filters overused?
- Clinical decision rules similarly effective in excluding PE
- YEARS algorithm helpful for evaluating suspected PE in pregnant women
- Warfarin therapy
- LMWH = UFH for thrombocytopenia
- Thrombolysis for PE reduces rate of all-cause mortality but increases risk of major bleeding
- Combined intermittent pneumatic leg compression and pharmacological prophylaxis for prevention of venous thromboembolism
- Oral rivaroxaban as effective as standard therapy for treatment of acute PE
- Fibrinolysis for intermediate-risk PE: increased bleeding, no mortality effect
- Continuing warfarin for 18 months after unprovoked PE reduces risk of recurrent VTE
- Wells score plus age-adjusted d-dimer rules out more PEs
- Low risk of DVT after knee arthroscopy
- Temporary IVC filter added to anticoagulation does not decrease risk of PE recurrence
- Aspirin prevents recurrent venous thromboembolism
- Remote appointments
- Evaluation of thrombophilia
- Low-risk patients with PE can be treated as outpatients
- Sinus tachycardia
- Pharmacological interventions for preventing venous thromboembolism in people undergoing bariatric surgery
- Age-adjusted D-dimer cutoff levels more accurate for PE diagnosis (ADJUST-PE)
- Third-generation oral contraceptives associated with greater risk of PE, stroke, and MI
- Increasing the D-dimer threshold for patients with low clinical pretest probability effectively rules out PE (PEGeD)
- Idraparinux effective for DVT but not for PE
- Thromboembolism recurrence likely; consider it a chronic disease (MARVELOUS)
- Edoxaban noninferior to warfarin for venous thromboembolism anticoagulation
- Anticoagulants for people hospitalised with COVID‐19
- Combined intermittent pneumatic compression and pharmacological prophylaxis for prevention of venous thromboembolism